Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Regeneron
Company Monitoring Page for Regeneron
latest headlines for company on cafepharma
Sanofi/Regeneron’s Dupixent shows more promise in nasal polyps
Pharmaforum
Tue, 02/26/19 - 11:48 pm
Tags:
Sanofi
,
Regeneron
,
Dupixent
,
clinical trials
,
nasal polyps
Regeneron touts one-year diabetic retinopathy data for Eylea
Drug Delivery Business News
Mon, 02/11/19 - 11:44 pm
Tags:
Regeneron
,
Eylea
,
proliferative diabetic retinopathy
Regeneron, Sanofi cut PCSK9 list price, matching earlier move by rival Amgen
Biopharma Dive
Mon, 02/11/19 - 12:23 pm
Tags:
Regeneron
,
Sanofi
,
Amgen
,
Praluent
,
Repatha
,
drug pricing
,
PCSK9 inhibitors
Forget Bristol-Myers: Regeneron takes on Merck for the heavyweight title in non-small cell lung cancer
Endpoints
Fri, 02/8/19 - 11:40 am
Tags:
Regeneron
,
Merck
,
Bristol-Myers Squibb
,
PD-1/L1 therapy
,
Libtayo
,
Keytruda
,
Opdivo
,
non-small cell lung cancer
Successful launch bolsters Libtayo's place as cornerstone therapy for Regeneron
Biopharma Dive
Wed, 02/6/19 - 03:57 pm
Tags:
Regeneron
,
Libtayo
,
earnings
,
CSCC
,
drug launches
Report: five companies would take brunt of Trump Part B proposal
BioCentury
Fri, 02/1/19 - 11:24 am
Tags:
Donald Trump
,
Medicare Part B
,
Amgen
,
Regeneron
,
Bristol-Myers Squibb
,
Genentech
,
Roche
Is the Smoldering NASH Market Ready to Burst Into Flames?
BioSpace
Tue, 01/22/19 - 11:52 am
Tags:
NASH
,
Allergan
,
Regeneron
,
Alnylam
,
AstraZeneca
,
Merck
,
Takeda
,
Gilead Sciences
,
Bristol-Myers Squibb
,
Intercept Pharmaceuticals
Day One of JPM Brings Excitement and Promise for a New Year in Biotech and Pharma
BioSpace
Wed, 01/9/19 - 09:40 am
Tags:
JPMHC 2019
,
M&A
,
Eli Lilly
,
Loxo Oncology
,
SAGE Therapeutics
,
Sanofi
,
Regeneron
,
Bristol-Myers Squibb
,
Celgene
,
Novartis
,
Gilead Sciences
Sanofi pays Regeneron $462M to exit immuno-oncology R&D pact
Fierce Biotech
Mon, 01/7/19 - 10:10 am
Tags:
Sanofi
,
Regeneron
,
immuno-oncology
7 drugs that raised eyebrows in Q3
Biopharma Dive
Thu, 11/15/18 - 11:50 pm
Tags:
Sanofi
,
Dupixent
,
Roche
,
Herceptin
,
AbbVie
,
Humira
,
Regeneron
,
Repatha
,
Clovis Oncology
,
Rubraca
,
GSK
,
Shingrix
,
Eli Lilly
,
Trulicity
Going gangbusters in atopic dermatitis, the FDA hands Sanofi and Regeneron a fresh coup for their mega-blockbuster star Dupixent
Endpoints
Tue, 11/6/18 - 09:48 am
Tags:
Sanofi
,
Regeneron
,
Dupixent
,
atopic dermatitis
Early November Brings More Quarterly Reports
BioSpace
Sun, 11/4/18 - 02:38 pm
Tags:
earnings
,
Akcea
,
Mylan
,
Eli Lilly
,
Regeneron
Roche expands its PhIII program for Eylea rival as long-acting data back its blockbuster contender faricimab
Endpoints
Mon, 10/29/18 - 10:27 am
Tags:
Roche
,
Genentech
,
Regeneron
,
Novartis
,
Eylea
,
faricimab
,
wet-AMD
Regeneron and Roche Duke it Out in the Diabetic Retinopathy Market
BioSpace
Thu, 10/25/18 - 11:43 am
Tags:
Regeneron
,
Eylea
,
diabetic retinopathy
,
Roche
,
Lucentis
FDA kicks Regeneron’s latest Eylea application to the curb, but they’re not sweating it
Endpoints
Thu, 10/25/18 - 09:56 am
Tags:
Regeneron
,
FDA
,
Eylea
,
complete response letter
Regeneron, Sanofi talks up potential blockbuster franchise as Dupixent sweeps in rhinosinusitis PhIII
Endpoints
Tue, 10/16/18 - 11:44 am
Tags:
Regeneron
,
Sanofi
,
Dupixent
,
nasal polyps
,
rhinosinusitis
7 drugmakers to watch during Q3 earnings
Biopharma Dive
Mon, 10/15/18 - 12:31 pm
Tags:
earnings
,
Novartis
,
Gilead Sciences
,
Amgen
,
Pfizer
,
GSK
,
AbbVie
,
Regeneron
In Medical Reporting, the Impact of Patients’ Stories
NY Times, NY
Tue, 10/9/18 - 04:47 pm
Tags:
patients
,
journalists
,
Regeneron
Regeneron, Sanofi Win Approval for Their First Immuno-Oncology Drug
Bloomberg
Sat, 09/29/18 - 12:12 pm
Tags:
Regeneron
,
Sanofi
,
Libtayo
,
immuno-oncology
,
skin cancer
,
FDA
3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph
Yahoo/Motley Fool
Thu, 09/27/18 - 10:07 am
Tags:
Amarin
,
Vascepa
,
Amgen
,
Sanofi
,
Regeneron
Pages
« first
‹ previous
…
17
18
19
20
21
22
23
24
25
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.